HIGHFDA DEVICE

Beckman Coulter Recalls 160 DxC 500i Modules and DxI 9000 Analyzers in 2025 Recall

Beckman Coulter recalls 160 DxC 500i Clinical Analyzer Modules and the DxI 9000 Access Immunoassay Analyzer worldwide after a software anomaly could misapply manual dilution factors. The defect affects samples already in progress using the same Sample ID. Stop using the devices immediately and follow the recall instructions. Beckman Coulter will provide instructions via the recall process.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
September 19, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 19, 2025
Hazard Level
HIGH
Brand
Beckman Coulter
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Beckman Coulter
Product type
DxC 500i Clinical Analyzer Modules and DxI 9000 Access Immunoassay Analyzer
Model numbers
C63522, C63521, C13252
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 19, 2025

  2. Reported by FDA DEVICE

    October 29, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Beckman Coulter has confirmed a software anomaly on DxI 9000 Access Immunoassay Analyzer and the DxC 500i Clinical Analyzer that may prevent correct application of user-specified manual dilution factors when ordering additional tests for samples already "In Progress" using the same "Sample ID number". This can lead to false low or high patient results and potential delays in reporting, risking erroneous diagnoses if undetected.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Beckman Coulter, Inc. or your healthcare provider for instructions. Notification method: Letter

About This Product

DxC 500i modules and the DxI 9000 Access Immunoassay Analyzer are clinical laboratory instruments used for chemistry and immunoassay testing in healthcare settings.

Why This Is Dangerous

A software anomaly can misapply manual dilution factors for tests ordered on samples in progress, risking inaccurate results and delayed reporting.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

The defect could lead to incorrect patient results and reporting delays, potentially impacting diagnosis and treatment.

Practical Guidance

How to identify if yours is affected

  1. 1) Confirm device model numbers C63522, C63521, or C13252.
  2. 2) Verify serial numbers against the recall serial list.
  3. 3) Check for any recall communications from Beckman Coulter.
  4. 4) Quarantine affected devices and contact Beckman Coulter for instructions.

Where to find product info

Recall notice and enforcement page at the FDA link: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-0215-2026

What timeline to expect

Resolution or remediation guidance will be provided by Beckman Coulter through the recall letter. Expect weeks to months depending on device and site.

If the manufacturer is unresponsive

  • Escalate to institutional biosafety or biomedical engineering leadership.
  • File a formal request for remediation with Beckman Coulter if no response within stated timeframes.
  • If needed, consult regulatory authorities for guidance on device safety.

How to prevent similar issues

  • Only install software updates released by Beckman Coulter through official channels.
  • Periodically verify test dilution procedures in practice to minimize risk before remediation is available.
  • Maintain an inventory of affected devices and store recall communications securely.

Documentation advice

Keep the recall notification, serial/model lists, and all correspondence with Beckman Coulter for future reference.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Models C63522, C63521, C13252
  • Serial numbers listed in recall
  • Software anomaly affects manual dilution factors
  • Hospital/clinical facility users should stop use immediately

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeDxC 500i Clinical Analyzer Modules and DxI 9000 Access Immunoassay Analyzer
Sold At
Multiple Retailers

Product Details

Model Numbers
C63522
C63521
C13252
Affected States
ALL
Report Date
October 29, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

Beckman Coulter Recalls Diluent Due to Elevated Platelet Counts

Beckman Coulter recalled 76,098 units of COULTER DxH Diluent on November 10, 2025. The recall affects specific lots contributing to elevated platelet background counts in analyzers. Healthcare providers and patients must stop using this product immediately.

Beckman Coulter
Due to
Read more